NCT01919593

Brief Summary

To evaluate the efficacy of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine in reducing blood culture contamination in pediatric patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,269

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 9, 2013

Completed
Last Updated

August 13, 2013

Status Verified

August 1, 2013

Enrollment Period

11 months

First QC Date

August 6, 2013

Last Update Submit

August 9, 2013

Conditions

Keywords

Blood cultureContaminationChlorhexidine gluconatePovidone iodine

Outcome Measures

Primary Outcomes (1)

  • efficacy of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine

    Pediatric patients who needed percutaneous blood cultures were recruited and were assigned 10% povidone iodine in odd months and 2% chlorhexidine gluconate in 70% alcohol in even months as an antiseptic for blood cultures. Blood culture isolates were categorized into two groups including a true pathogen and a contaminant by clinical criteria combined with laboratory data.

    5 days

Secondary Outcomes (1)

  • safety of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine

    48 hours

Study Arms (2)

2% Chlorhexidine Gluconate

EXPERIMENTAL

apply 2% Chlorhexidine Gluconate in 70% Alcohol on skin before venipuncture

Drug: 2% chlorhexidine gluconate in 70% alcohol

10% povidone iodine

ACTIVE COMPARATOR

apply 10% povidone iodine on the skin before venipuncture

Drug: 10%povidone iodine

Interventions

skin preparation before venipuncture for blood culture in even month

Also known as: Chloraprep
2% Chlorhexidine Gluconate

skin preparation before venipuncture for blood culture in odd month

Also known as: Betadine
10% povidone iodine

Eligibility Criteria

Age1 Day - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients between 0-15 years of age who were admitted in three pediatric wards: general pediatric ward aged \<5 years, general pediatric ward aged \>5 years, and pediatric intensive care unit. Patients who needed percutaneous blood cultures were eligible for enrollment.

You may not qualify if:

  • Preterm infant
  • Patient who had skin infection at site of venepuncture
  • Patient who had history allergy to 2% Chlorhexidine gluconate in 70% alcohol or 10% povidone-iodine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thammasat University hospital

Klong Luang, Pathumthanii, 10900, Thailand

Location

MeSH Terms

Conditions

Bacteremia

Interventions

chlorhexidine gluconateEthanolPovidone-Iodine

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsIodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Auchara Tangsathapornponng, MD

    Faculty of Medicine, Thammasat University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 6, 2013

First Posted

August 9, 2013

Study Start

January 1, 2012

Primary Completion

December 1, 2012

Study Completion

April 1, 2013

Last Updated

August 13, 2013

Record last verified: 2013-08

Locations